Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostatic osteoblastic factor.

S C Jacobs, D Pikna, R K Lawson

    Investigative Urology
    |November 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Prostate tissue extracts, particularly from benign prostatic hyperplasia, stimulate bone cell growth. This suggests a unique prostatic factor may drive the bone response seen in metastatic prostate cancer.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Managed care, health care reform, and academic psychiatry.

    Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2014
    Same author

    The detrimental effect of poor early graft function after laparoscopic live donor nephrectomy on graft outcomes.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2008
    Same author

    Warm ischemia time does not correlate with recipient graft function in laparoscopic donor nephrectomy.

    Surgical endoscopy·2003
    Same author

    Induction of apoptosis in the prostate by alpha1-adrenoceptor antagonists: a novel effect of "old" drugs.

    Current urology reports·2002
    Same author

    Laparoscopic right donor nephrectomy: technique and comparison with left nephrectomy.

    Surgical endoscopy·2002
    Same author

    Perspectives on care at the close of life. Caring for bereaved patients: "all the doctors just suddenly go".

    JAMA·2001
    Same journal

    Post ischemic renal bleeding from fenal puncture site.

    Investigative urology·1981
    Same journal

    Vasoactive intestinal polypeptide (VIP) in the male genitourinary tract: concentration and motor effect.

    Investigative urology·1981
    Same journal

    Enzymatic changes in experimental testicular torsion.

    Investigative urology·1981
    Same journal

    Effects of DES on the morphology of the lobes of the baboon prostate.

    Investigative urology·1981
    Same journal

    Nucleation kinetics in the calcium oxalate-sodium urate monohydrate system.

    Investigative urology·1981
    Same journal

    Plasma lipid bound sialic acid in patients with prostate and bladder cancer.

    Investigative urology·1981
    See all related articles

    Area of Science:

    • Biochemistry
    • Oncology
    • Cell Biology

    Background:

    • Metastatic prostate cancer frequently causes osteoblastic bone lesions.
    • The underlying mechanisms driving this bone response are not fully understood.
    • Prostatic tissue may contain factors influencing bone cell activity.

    Purpose of the Study:

    • To investigate the effects of prostatic tissue extracts on bone cell growth.
    • To identify potential factors in prostate tissue that influence bone metabolism.
    • To explore the hypothesis that prostatic factors induce osteoblastic responses in bone.

    Main Methods:

    • Utilized cell cultures of fetal rat osteoblasts and organ cultures of fetal rat calvaria.
    • Assessed the incorporation of 3H-thymidine and 14C-proline in response to prostatic extracts.

    Related Experiment Videos

  • Tested extracts from benign prostatic hyperplasia, prostatic carcinoma (undifferentiated and well-differentiated), and normal prostate tissue.

    • Main Results:

    • Extracts from benign prostatic hyperplasia stimulated osteoblast and fibroblast proliferation (3H-thymidine and 14C-proline incorporation).
    • Undifferentiated prostatic carcinoma extracts did not stimulate osteoblast or fibroblast proliferation.
    • Well-differentiated prostatic cancer and normal prostate extracts stimulated fibroblast proliferation (3H-thymidine incorporation).

    Conclusions:

    • Findings support the existence of a unique factor in prostatic tissue.
    • This factor appears to induce an osteoblastic response in bone, relevant to metastatic prostate cancer.
    • The study provides evidence for a molecular link between prostate cancer and bone remodeling.